Alisol A Suppresses Proliferation, Migration, and Invasion in Human Breast Cancer MDA-MB-231 Cells
- Molecules. 2019 Oct 10;24(20):3651. doi: 10.3390/molecules24203651.
- 1. School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. [email protected].
- 2. School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. [email protected].
- 3. School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. [email protected].
- 4. School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. [email protected].
Natural products are a precious source of promising leads for the development of novel Cancer therapeutics. Recently, triterpenoids in Alismatis rhizoma has been widely demonstrated for their anti-cancer activities in Cancer cells. In this study, we examined the inhibitory effects of alisol A in human breast Cancer cells. We demonstrated that alisol A exhibited significant anti-proliferative effects in MDA-MB-231 cells and this response was related to Autophagy induction. Alisol A-induced Autophagy was supported by the triggered autophagosome formation and increased LC3-II levels. Interestingly, Autophagy inhibitor 3-MA significantly reversed the cytotoxic effects induced by alisol A. Meanwhile, alisol A-induced Autophagy was significantly inhibited by 3-MA in MDA-MB-231 cells. Cell cycle analysis revealed that alisol A arrested the cell cycle at G0/G1 phase. The expression level of cell cycle regulatory proteins cyclin D1 was significantly down regulated. In addition, the suppression of NF-κB and PI3K/Akt/mTOR pathways in MDA-MB-231 cells was observed. Furthermore, alisol A significantly suppressed the migration and invasion of MDA-MB-231 cells by inhibiting the expression levels of MMP-2 and MMP-9. Taken together, our results demonstrated that alisol A could inhibit the proliferation and metastasis of MDA-MB-231 cells. It could be a promising agent for breast Cancer therapy.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Neurological Disease; Metabolic Disease; Inflammation/Immunology; Infection; Cardiovascular Disease; Cancer